AGP Picks
View all

Health Professional Times
Provided by AGP

Health Professional Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Professional Times.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on April 17, 2026

Alterity Therapeutics Appoints Highly Experienced Biotech Executive Ann Cunningham to its Board of Directors
Apr. 17, 2026

Alterity Therapeutics Appoints Highly Experienced Biotech Executive Ann Cunningham to its Board of Directors

Indeterminate GlobeNewswire
BioXcel Therapeutics Announces Virtual Event to Discuss Commercial Launch Plan Based on Market Opportunity Assessment for IGALMI® in the At-Home Setting
Apr. 17, 2026

BioXcel Therapeutics Announces Virtual Event to Discuss Commercial Launch Plan Based on Market Opportunity Assessment for IGALMI® in the At-Home Setting

Indeterminate GlobeNewswire
Upstream Bio to Present New Data from Phase 2 VIBRANT Trial of Verekitug at the ATS 2026 International Conference
Apr. 17, 2026

Upstream Bio to Present New Data from Phase 2 VIBRANT Trial of Verekitug at the ATS 2026 International Conference

Indeterminate GlobeNewswire
Yaqrit Phase 2a data, clinical consensus boost YAQ007 and YAQ006 in Hepatic Encephalopathy
Apr. 17, 2026

Yaqrit Phase 2a data, clinical consensus boost YAQ007 and YAQ006 in Hepatic Encephalopathy

Indeterminate GlobeNewswire
Invest in the Future of Clean Energy Drinks: US Capital Global Securities Announces $10 Million Offering for G.O.A.T. Fuel
Apr. 17, 2026

Invest in the Future of Clean Energy Drinks: US Capital Global Securities Announces $10 Million Offering for G.O.A.T. Fuel

Indeterminate GlobeNewswire
Kura Oncology Reports Darlifarnib Plus Cabozantinib Demonstrates Robust Activity in Patients With Clear Cell Renal Cell Carcinoma Previously Treated With Cabozantinib
Apr. 17, 2026

Kura Oncology Reports Darlifarnib Plus Cabozantinib Demonstrates Robust Activity in Patients With Clear Cell Renal Cell Carcinoma Previously Treated With Cabozantinib

Indeterminate GlobeNewswire
Immuron Double Digit 3Q Sales Growth
Apr. 17, 2026

Immuron Double Digit 3Q Sales Growth

Indeterminate GlobeNewswire
New Nordic white paper reveals systemic barriers preventing women from reaching leadership roles
Apr. 17, 2026

New Nordic white paper reveals systemic barriers preventing women from reaching leadership roles

Indeterminate GlobeNewswire
Bioxodes expands Clinical Advisory Board, shares pivotal trial design for BIOX-101 in intracerebral hemorrhage
Apr. 17, 2026

Bioxodes expands Clinical Advisory Board, shares pivotal trial design for BIOX-101 in intracerebral hemorrhage

Indeterminate GlobeNewswire
Carbios announces fiscal-year 2025 financial results
Apr. 17, 2026

Carbios announces fiscal-year 2025 financial results

Indeterminate GlobeNewswire
CARBIOS présente ses résultats annuels 2025
Apr. 17, 2026

CARBIOS présente ses résultats annuels 2025

Indeterminate GlobeNewswire
Trevi Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock
Apr. 17, 2026

Trevi Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock

Indeterminate GlobeNewswire
OraSure Technologies Appoints John D. Bertrand to its Board of Directors
Apr. 17, 2026

OraSure Technologies Appoints John D. Bertrand to its Board of Directors

Indeterminate GlobeNewswire

Share this page:

Sign up for:

Health Professional Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.